About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Insulin Therapy in the Hospital Comparing Two Protocols

NCT00841919·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Cook County Health

With

Eli Lilly and Company

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Uncontrolled blood sugar:
* Random blood sugar ≥ 200mg/dl
* Pre-prandial blood sugar greater than 180 mg/dl on two occasions within 24 hours.
Patient may be off insulin or on subcutaneous inpatient insulin regimen less than 36 hours.
Transition from an Insulin Drip in the intensive care units to subcutaneous insulin upon transfer to general ward.
Patient is able to eat and oral feeding is expected.

You may not be if

Patients receiving inpatient oral hypoglycemic agents
Patients with chronic kidney disease stages 4 \& 5 (estimated GFR of \<30ml/min) and on dialysis
Patient with chronic liver disease
Patient with hypoglycemia unawareness
Pregnancy
Patients who are on "NPO" for medical reasons.
Patient is expected to stay in the hospital for less than 3 days.
Patient on a new inpatient insulin regimen for \> 36 hours.

The record

StatusCompleted

PhasePhase 4

Taking part60

StartedDec 2006

UpdatedSep 9, 2009

Conditions

Diabetes Mellitus, Type 2

Where1

John H Stroger Jr. Hospital
Chicago, Illinois, United States

Clareo Health | Insulin Therapy in the Hospital Comparing Two Protocols